Stams Diagnostics

Company profile

Stams Diagnostics company profile

Next Generation Human Serum Albumin Nanoparticles for the Application in Theranostics Stams Diagnostics has solved the challenges of creating nanoparticles for specific targeting and cell uptake. Defined uniform size. Stochiometric attachment of targeting groups. Defined attachment of imaging groups or other effector molecules. Rapid, specific and stable target binding within a few minutes. High in vivo stability. Resistant to conditions in the gastrointestinal tract. Non-aggregating. Non-toxicity. Cost-effective production. Straightforward upscalability. Fridge storage life exceeds two years. Compatible with all conventional fluorochromes. Ready for polychromatic imaging of different targets.